Biggest News Aggregation in the World
📰 Current Reports News

Page 33 - Current Reports News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Current Reports. Real-time updates on events, politics, business and more.

Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung…

  Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally...
Abderrahim Oukessou Bristol Myers Squibb Exchange Commission European Commission Regulatory Agency Bristol Myers Squibb Announces Pivotal

Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn's Disease -March 28, 2024 at 04:02 pm EDT

Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia ...
Roland Chen Bristol Myers Squibb Exchange Commission Clinical Trial Program Bristol Myers Disease Activity Index

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Iteris Awarded $9.6 Million Contract by the Orange County Transportation Authority for Countywide Smart Mobility Initiative

SANTA ANA, Calif., March 27, 2024--Iteris, Inc. (NASDAQ: ITI), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced it has been awarded a new contract by the Orange County Transportation Authority (OCTA) for an unprecedented countywide traffic signal synchronization project that will ultimately increase efficiency, safety and sustainability across the entire county.
United States Orange County Todd Kehrli Bernard Li Iteri Clearmobility Breanna Wallace
Source: yahoo.com

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab

SAN DIEGO, March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today
San Diego United States Roberte Hoffman Company Quarterly Reports On Form National Institutes Of Health Company Annual Report On Form

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science